Technical Analysis for ACRS - Aclaris Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Parabolic Rise | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| New 52 Week Closing High | Bullish | -13.73% | |
| Expansion Breakout | Bullish Swing Setup | -13.73% | |
| Pocket Pivot | Bullish Swing Setup | -13.73% | |
| Volume Surge | Other | -13.73% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | about 17 hours ago |
| Possible Inside Day | about 18 hours ago |
| Down 2 ATRs | about 18 hours ago |
| 60 Minute Opening Range Breakdown | about 19 hours ago |
| 2x Volume Pace | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/04/2024
Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.17 |
| 52 Week Low | 0.77 |
| Average Volume | 2,505,545 |
| 200-Day Moving Average | 1.32 |
| 50-Day Moving Average | 1.65 |
| 20-Day Moving Average | 2.36 |
| 10-Day Moving Average | 2.86 |
| Average True Range | 0.46 |
| RSI (14) | 72.22 |
| ADX | 51.04 |
| +DI | 51.35 |
| -DI | 9.06 |
| Chandelier Exit (Long, 3 ATRs) | 3.80 |
| Chandelier Exit (Short, 3 ATRs) | 2.58 |
| Upper Bollinger Bands | 3.90 |
| Lower Bollinger Band | 0.83 |
| Percent B (%b) | 1.02 |
| BandWidth | 129.99 |
| MACD Line | 0.55 |
| MACD Signal Line | 0.38 |
| MACD Histogram | 0.1745 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.12 | ||||
| Resistance 3 (R3) | 5.15 | 4.79 | 4.92 | ||
| Resistance 2 (R2) | 4.79 | 4.50 | 4.78 | 4.86 | |
| Resistance 1 (R1) | 4.38 | 4.32 | 4.20 | 4.35 | 4.79 |
| Pivot Point | 4.02 | 4.02 | 3.94 | 4.01 | 4.02 |
| Support 1 (S1) | 3.61 | 3.73 | 3.43 | 3.58 | 3.13 |
| Support 2 (S2) | 3.25 | 3.55 | 3.24 | 3.06 | |
| Support 3 (S3) | 2.84 | 3.25 | 3.00 | ||
| Support 4 (S4) | 2.81 |
